Cargando…
Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?
The use of the adjuvant therapeutic antibody trastuzumab in breast cancer is associated with a range of cardiotoxic side effects despite successfully reducing the severity of outcomes cancer patients,. The most common cardiac effect, a reduction in left ventricular ejection fraction (LVEF), is a kno...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127350/ https://www.ncbi.nlm.nih.gov/pubmed/37098605 http://dx.doi.org/10.1186/s40959-023-00172-3 |